A-1
Corteva, Inc.
Consolidated Statements of Operations
(Dollars in millions, except per share amounts)

| Three Months Ended December 31, |  | Twelve Months Ended December 31,
| 2025 |  | 2024 |  | 2025 |  | 2024
Net sales | $ | 3,910 |  |  | $ | 3,978 |  |  | $ | 17,401 |  |  | $ | 16,908 |
Cost of goods sold | 2,254 |  |  | 2,496 |  |  | 9,172 |  |  | 9,529 |
Research and development expense | 413 |  |  | 365 |  |  | 1,474 |  |  | 1,402 |
Selling, general and administrative expenses | 860 |  |  | 735 |  |  | 3,492 |  |  | 3,196 |
Amortization of intangibles | 159 |  |  | 164 |  |  | 644 |  |  | 685 |
Restructuring and asset related charges - net | 15 |  |  | 89 |  |  | 146 |  |  | 288 |
Separation costs | 28 |  |  | — |  |  | 35 |  |  | — |
Other income (expense) - net | (665) |  |  | 19 |  |  | (570) |  |  | (300) |
Interest expense | 46 |  |  | 60 |  |  | 180 |  |  | 233 |
Income (loss) from continuing operations before income taxes | (530) |  |  | 88 |  |  | 1,688 |  |  | 1,275 |
Provision for (benefit from) income taxes on continuing operations | 7 |  |  | 138 |  |  | 484 |  |  | 412 |
Income (loss) from continuing operations after income taxes | (537) |  |  | (50) |  |  | 1,204 |  |  | 863 |
Income (loss) from discontinued operations after income taxes | (12) |  |  | 11 |  |  | (99) |  |  | 56 |
Net income (loss) | (549) |  |  | (39) |  |  | 1,105 |  |  | 919 |
Net income (loss) attributable to noncontrolling interests | 3 |  |  | 2 |  |  | 11 |  |  | 12 |
Net income (loss) attributable to Corteva | $ | (552) |  |  | $ | (41) |  |  | $ | 1,094 |  |  | $ | 907 |
Basic earnings (loss) per share of common stock: |  |  |  |  |  |  |
Basic earnings (loss) per share of common stock from continuing operations | $ | (0.80) |  |  | $ | (0.08) |  |  | $ | 1.75 |  |  | $ | 1.23 |
Basic earnings (loss) per share of common stock from discontinued operations | (0.02) |  |  | 0.02 |  |  | (0.15) |  |  | 0.08 |
Basic earnings (loss) per share of common stock | $ | (0.82) |  |  | $ | (0.06) |  |  | $ | 1.60 |  |  | $ | 1.31 |
Diluted earnings (loss) per share of common stock: |  |  |  |  |  |  |
Diluted earnings (loss) per share of common stock from continuing operations | $ | (0.80) |  |  | $ | (0.08) |  |  | $ | 1.75 |  |  | $ | 1.22 |
Diluted earnings (loss) per share of common stock from discontinued operations | (0.02) |  |  | 0.02 |  |  | (0.15) |  |  | 0.08 |
Diluted earnings (loss) per share of common stock | $ | (0.82) |  |  | $ | (0.06) |  |  | $ | 1.60 |  |  | $ | 1.30 |
Average number of shares outstanding used in earnings (loss) per share (EPS) calculation (in millions) |  |  |  |  |  |  |
Basic | 674.7 |  | 687.3 |  | 680.0 |  | 693.7
Diluted | 674.7 |  | 687.3 |  | 681.4 |  | 696.0

A-2
Corteva, Inc.
Consolidated Balance Sheets
(Dollars in millions, except share amounts)

|  | December 31, 2025 |  | December 31, 2024
Assets |  |  |  |
Current assets |  |  |  |
Cash and cash equivalents |  | $ | 4,521 |  |  | $ | 3,106 |
Marketable securities |  | 9 |  |  | 63 |
Accounts and notes receivable - net |  | 6,371 |  |  | 5,676 |
Inventories |  | 5,667 |  |  | 5,432 |
Other current assets |  | 767 |  |  | 820 |
Total current assets |  | 17,335 |  |  | 15,097 |
Investment in nonconsolidated affiliates |  | 160 |  |  | 134 |
Property, plant and equipment |  | 9,551 |  |  | 9,074 |
Less: Accumulated depreciation |  | 5,331 |  |  | 4,975 |
Net property, plant and equipment |  | 4,220 |  |  | 4,099 |
Goodwill |  | 10,465 |  |  | 10,408 |
Other intangible assets |  | 8,301 |  |  | 8,876 |
Deferred income taxes |  | 320 |  |  | 401 |
Other assets |  | 2,044 |  |  | 1,810 |
Total Assets |  | $ | 42,845 |  |  | $ | 40,825 |
Liabilities and Equity |  |  |  |
Current liabilities |  |  |  |
Short-term borrowings and finance lease obligations |  | $ | 894 |  |  | $ | 750 |
Accounts payable |  | 4,398 |  |  | 4,039 |
Income taxes payable |  | 155 |  |  | 207 |
Deferred revenue |  | 3,579 |  |  | 3,287 |
Accrued and other current liabilities |  | 3,099 |  |  | 2,103 |
Total current liabilities |  | 12,125 |  |  | 10,386 |
Long-term debt |  | 1,686 |  |  | 1,953 |
Other noncurrent liabilities |  |  |  |
Deferred income tax liabilities |  | 251 |  |  | 478 |
Pension and other post-employment benefits |  | 2,434 |  |  | 2,271 |
Other noncurrent obligations |  | 1,963 |  |  | 1,707 |
Total noncurrent liabilities |  | 6,334 |  |  | 6,409 |
Commitments and contingent liabilities |  |  |  |
Stockholders' equity |  |  |  |
Common stock, $0.01 par value;1,666,667,000 shares authorized; issued at December 31, 2025 - 672,163,000 and December 31, 2024 - 685,595,000 |  | 7 |  |  | 7 |
Additional paid-in capital |  | 27,001 |  |  | 27,196 |
Retained earnings (accumulated deficit) |  | (67) |  |  | 55 |
Accumulated other comprehensive income (loss) |  | (2,797) |  |  | (3,469) |
Total Corteva stockholders' equity |  | 24,144 |  |  | 23,789 |
Noncontrolling interests |  | 242 |  |  | 241 |
Total equity |  | 24,386 |  |  | 24,030 |
Total Liabilities and Equity |  | $ | 42,845 |  |  | $ | 40,825 |

A-3
Corteva, Inc.
Consolidated Statements of Cash Flows
(Dollars in millions, except per share amounts)

| Twelve Months Ended December 31,
| 2025 |  | 2024
Operating activities |  |  |
Net income (loss) | $ | 1,105 |  |  | $ | 919 |
(Income) loss from discontinued operations after income taxes | 99 |  |  | (56) |
Adjustments to reconcile net income (loss) to cash provided by (used for) operating activities |  |  |
Depreciation and amortization | 1,203 |  |  | 1,227 |
Provision for (benefit from) deferred income tax | (41) |  |  | (365) |
Net periodic pension and OPEB (benefit) cost, net | 36 |  |  | 160 |
Pension and OPEB contributions | (136) |  |  | (151) |
Net (gain) loss on sales of property, businesses, consolidated companies, and investments | (41) |  |  | (17) |
Restructuring and asset related charges - net | 147 |  |  | 288 |
Other net loss | 545 |  |  | 383 |
Changes in assets and liabilities, net |  |  |
Accounts and notes receivable | (261) |  |  | (705) |
Inventories | (35) |  |  | 1,110 |
Accounts payable | 231 |  |  | (115) |
Deferred revenue | 270 |  |  | (86) |
Other assets and liabilities | 335 |  |  | (296) |
Cash provided by (used for) operating activities - continuing operations | $ | 3,457 |  |  | $ | 2,296 |
Cash provided by (used for) operating activities - discontinued operations | (51) |  |  | (151) |
Cash provided by (used for) operating activities | $ | 3,406 |  |  | $ | 2,145 |
Investing activities |  |  |
Capital expenditures | $ | (591) |  |  | $ | (597) |
Proceeds from sales of property, businesses, and consolidated companies - net of cash divested | 54 |  |  | 5 |
Investments in and loans to nonconsolidated affiliates | (20) |  |  | (7) |
Purchases of investments | — |  |  | (144) |
Proceeds from sales and maturities of investments | 135 |  |  | 130 |
Proceeds from (payments for) settlement of net investment hedge | (83) |  |  | 63 |
Other investing activities, net | (38) |  |  | (39) |
Cash provided by (used for) investing activities | $ | (543) |  |  | $ | (589) |
Financing activities |  |  |
Net change in borrowings (less than 90 days) | $ | — |  |  | $ | 53 |
Proceeds from debt | 1,730 |  |  | 3,072 |
Payments on debt | (1,871) |  |  | (2,885) |
Repurchase of common stock | (1,071) |  |  | (1,009) |
Proceeds from exercise of stock options | 88 |  |  | 60 |
Dividends paid to stockholders | (475) |  |  | (458) |
Other financing activities, net | (45) |  |  | (32) |
Cash provided by (used for) financing activities | $ | (1,644) |  |  | $ | (1,199) |
Effect of exchange rate changes on cash, cash equivalents and restricted cash equivalents | 84 |  |  | (93) |
Increase (decrease) in cash, cash equivalents and restricted cash equivalents | $ | 1,303 |  |  | $ | 264 |
Cash, cash equivalents and restricted cash equivalents at beginning of period | 3,422 |  |  | 3,158 |
Cash, cash equivalents and restricted cash equivalents at end of period | $ | 4,725 |  |  | $ | 3,422 |

A-4
Corteva, Inc.
Consolidated Segment Information
(Dollars in millions, except per share amounts)

|  | Three Months Ended December 31, |  | Twelve Months Ended December 31,
SEGMENT NET SALES - SEED |  | 2025 |  | 2024 |  | 2025 |  | 2024
Corn |  | $ | 1,386 |  |  | $ | 1,411 |  |  | $ | 7,002 |  |  | $ | 6,496 |
Soybean |  | 164 |  |  | 154 |  |  | 1,878 |  |  | 1,927 |
Other oilseeds |  | 94 |  |  | 87 |  |  | 644 |  |  | 653 |
Other |  | 93 |  |  | 120 |  |  | 374 |  |  | 469 |
Seed |  | $ | 1,737 |  |  | $ | 1,772 |  |  | $ | 9,898 |  |  | $ | 9,545 |
|  | Three Months Ended December 31, |  | Twelve Months Ended December 31,
SEGMENT NET SALES - CROP PROTECTION |  | 2025 |  | 2024 |  | 2025 |  | 2024
Herbicides |  | $ | 1,062 |  |  | $ | 1,031 |  |  | $ | 3,730 |  |  | $ | 3,599 |
Insecticides |  | 488 |  |  | 490 |  |  | 1,669 |  |  | 1,715 |
Fungicides |  | 272 |  |  | 320 |  |  | 1,140 |  |  | 1,081 |
Biologicals |  | 191 |  |  | 169 |  |  | 519 |  |  | 476 |
Other |  | 160 |  |  | 196 |  |  | 445 |  |  | 492 |
Crop Protection |  | $ | 2,173 |  |  | $ | 2,206 |  |  | $ | 7,503 |  |  | $ | 7,363 |
|  | Three Months Ended December 31, |  | Twelve Months Ended December 31,
GEOGRAPHIC NET SALES - SEED |  | 2025 |  | 2024 |  | 2025 |  | 2024
North America 1 |  | $ | 545 |  |  | $ | 639 |  |  | $ | 6,271 |  |  | $ | 6,033 |
EMEA 2 |  | 190 |  |  | 216 |  |  | 1,560 |  |  | 1,581 |
Latin America |  | 884 |  |  | 827 |  |  | 1,614 |  |  | 1,523 |
Asia Pacific |  | 118 |  |  | 90 |  |  | 453 |  |  | 408 |
Rest of World 3 |  | 1,192 |  |  | 1,133 |  |  | 3,627 |  |  | 3,512 |
Net Sales |  | $ | 1,737 |  |  | $ | 1,772 |  |  | $ | 9,898 |  |  | $ | 9,545 |
|  | Three Months Ended December 31, |  | Twelve Months Ended December 31,
GEOGRAPHIC NET SALES - CROP PROTECTION |  | 2025 |  | 2024 |  | 2025 |  | 2024
North America 1 |  | $ | 933 |  |  | $ | 924 |  |  | $ | 2,753 |  |  | $ | 2,627 |
EMEA 2 |  | 234 |  |  | 232 |  |  | 1,550 |  |  | 1,543 |
Latin America |  | 769 |  |  | 795 |  |  | 2,314 |  |  | 2,253 |
Asia Pacific |  | 237 |  |  | 255 |  |  | 886 |  |  | 940 |
Rest of World 3 |  | 1,240 |  |  | 1,282 |  |  | 4,750 |  |  | 4,736 |
Net Sales |  | $ | 2,173 |  |  | $ | 2,206 |  |  | $ | 7,503 |  |  | $ | 7,363 |
1. Reflects U.S. & Canada |  |  |  |  |  |  |  |
2. Reflects Europe, Middle East, and Africa |  |  |  |  |  |  |  |
3. Reflects EMEA, Latin America, and Asia Pacific |  |  |  |  |  |  |  |

A-5
Corteva, Inc.
Reconciliation of Non-GAAP Measures
(Dollars in millions, except per share amounts)

|  | Three Months Ended December 31, |  | Twelve Months Ended December 31,
|  | 2025 |  | 2025
Net Sales (GAAP) |  | $ | 3,910 |  |  | $ | 17,401 |
Add: Impacts from Currency and Portfolio / Other |  | (88) |  |  | 155 |
Organic Sales (Non-GAAP) |  | $ | 3,822 |  |  | $ | 17,556 |
|  | Three Months Ended December 31, |  | Twelve Months Ended December 31,
OPERATING EBITDA |  | 2025 |  | 2024 |  | 2025 |  | 2024
Seed |  | $ | 124 |  |  | $ | 93 |  |  | $ | 2,636 |  |  | $ | 2,219 |
Crop Protection |  | 360 |  |  | 461 |  |  | 1,350 |  |  | 1,272 |
Corporate Expenses |  | (38) |  |  | (29) |  |  | (138) |  |  | (115) |
Operating EBITDA (Non-GAAP) |  | $ | 446 |  |  | $ | 525 |  |  | $ | 3,848 |  |  | $ | 3,376 |
RECONCILIATION OF INCOME (LOSS) FROM CONTINUING OPERATIONS AFTER INCOME TAXES TO OPERATING EBITDA |  | Three Months Ended December 31, |  | Twelve Months Ended December 31,
| 2025 |  | 2024 |  | 2025 |  | 2024
Income (loss) from continuing operations after income taxes (GAAP) |  | $ | (537) |  |  | $ | (50) |  |  | $ | 1,204 |  |  | $ | 863 |
Provision for (benefit from) income taxes on continuing operations |  | 7 |  |  | 138 |  |  | 484 |  |  | 412 |
Income (loss) from continuing operations before income taxes (GAAP) |  | (530) |  |  | 88 |  |  | 1,688 |  |  | 1,275 |
Depreciation and amortization |  | 306 |  |  | 302 |  |  | 1,203 |  |  | 1,227 |
Interest income |  | (44) |  |  | (39) |  |  | (136) |  |  | (132) |
Interest expense |  | 46 |  |  | 60 |  |  | 180 |  |  | 233 |
Exchange (gains) losses - net 1 |  | 84 |  |  | 50 |  |  | 181 |  |  | 284 |
Non-operating (benefits) costs - net 2 |  | 12 |  |  | 42 |  |  | 39 |  |  | 174 |
Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges |  | (58) |  |  | 4 |  |  | — |  |  | — |
Significant items (benefit) charge 3 |  | 602 |  |  | 18 |  |  | 658 |  |  | 315 |
Separation costs |  | 28 |  |  | — |  |  | 35 |  |  | — |
Operating EBITDA (Non-GAAP) |  | $ | 446 |  |  | $ | 525 |  |  | $ | 3,848 |  |  | $ | 3,376 |

1.Refer to page A-15 for pre-tax and after tax impacts of exchange (gains) losses.
2.Non-operating (benefits) costs consists of non-operating pension and other post-employment benefit (OPEB) (credits) costs, tax indemnification adjustments and environmental remediation and legal costs associated with legacy businesses and sites. Tax indemnification adjustments relate to changes in indemnification balances, as a result of the application of the terms of the Tax Matters Agreement, between Corteva and Dow and/or DuPont that are recorded by the company as pre-tax income or expense.
3.Refer to page A-10 for pre-tax and after tax impacts of significant items.

A-6
Corteva, Inc.
Reconciliation of Non-GAAP Measures
(Dollars in millions, except per share amounts)

PRICE - VOLUME - CURRENCY ANALYSIS
REGION |  |
| Q4 2025 vs. Q4 2024 | Percent Change Due To:
| Net Sales Change (GAAP) | Organic Change 1 (Non-GAAP) | Price & |  |  | Portfolio /
| $ | % | $ | % | Product Mix | Volume | Currency | Other
North America | $ | (85) |  | (5) | % | $ | (85) |  | (5) | % | 1 | % | (6) | % | — | % | — | %
EMEA | (24) |  | (5) | % | (39) |  | (9) | % | 2 | % | (11) | % | 4 | % | — | %
Latin America | 31 |  | 2 | % | (55) |  | (3) | % | — | % | (3) | % | 5 | % | — | %
Asia Pacific | 10 |  | 3 | % | 23 |  | 7 | % | 2 | % | 5 | % | (4) | % | — | %
Rest of World | 17 |  | 1 | % | (71) |  | (3) | % | 1 | % | (4) | % | 4 | % | — | %
Total | $ | (68) |  | (2) | % | $ | (156) |  | (4) | % | 1 | % | (5) | % | 2 | % | — | %
SEED |  |  |  |  |  |  |  |
| Q4 2025 vs. Q4 2024 | Percent Change Due To:
| Net Sales Change (GAAP) | Organic Change 1 (Non-GAAP) | Price & |  |  | Portfolio /
| $ | % | $ | % | Product Mix | Volume | Currency | Other
North America | $ | (94) |  | (15) | % | $ | (94) |  | (15) | % | (3) | % | (12) | % | — | % | — | %
EMEA | (26) |  | (12) | % | (34) |  | (16) | % | 2 | % | (18) | % | 4 | % | — | %
Latin America | 57 |  | 7 | % | 8 |  | 1 | % | 7 | % | (6) | % | 6 | % | — | %
Asia Pacific | 28 |  | 31 | % | 35 |  | 39 | % | 9 | % | 30 | % | (8) | % | — | %
Rest of World | 59 |  | 5 | % | 9 |  | 1 | % | 6 | % | (5) | % | 4 | % | — | %
Total | $ | (35) |  | (2) | % | $ | (85) |  | (5) | % | 3 | % | (8) | % | 3 | % | — | %
CROP PROTECTION |  |  |  |  |  |  |
| Q4 2025 vs. Q4 2024 | Percent Change Due To:
| Net Sales Change (GAAP) | Organic Change 1 (Non-GAAP) | Price & |  |  | Portfolio /
| $ | % | $ | % | Product Mix | Volume | Currency | Other
North America | $ | 9 |  | 1 | % | $ | 9 |  | 1 | % | 4 | % | (3) | % | — | % | — | %
EMEA | 2 |  | 1 | % | (5) |  | (2) | % | 3 | % | (5) | % | 3 | % | — | %
Latin America | (26) |  | (3) | % | (63) |  | (8) | % | (7) | % | (1) | % | 5 | % | — | %
Asia Pacific | (18) |  | (7) | % | (12) |  | (5) | % | (1) | % | (4) | % | (2) | % | — | %
Rest of World | (42) |  | (3) | % | (80) |  | (6) | % | (4) | % | (2) | % | 3 | % | — | %
Total | $ | (33) |  | (1) | % | $ | (71) |  | (3) | % | (1) | % | (2) | % | 2 | % | — | %

A-7
Corteva, Inc.
Reconciliation of Non-GAAP Measures
(Dollars in millions, except per share amounts)

SEED PRODUCT LINE |  |  |  |  |  |  |
| Q4 2025 vs. Q4 2024 | Percent Change Due To:
| Net Sales Change (GAAP) | Organic Change 1 (Non-GAAP) | Price & |  |  | Portfolio /
| $ | % | $ | % | Product Mix | Volume | Currency | Other
Corn | $ | (25) |  | (2) | % | $ | (72) |  | (5) | % | 3 | % | (8) | % | 3 | % | — | %
Soybeans | 10 |  | 6 | % | 9 |  | 6 | % | 10 | % | (4) | % | — | % | — | %
Other oilseeds | 7 |  | 8 | % | 7 |  | 8 | % | 4 | % | 4 | % | — | % | — | %
Other | (27) |  | (23) | % | (29) |  | (24) | % | (8) | % | (16) | % | 1 | % | — | %
Total | $ | (35) |  | (2) | % | $ | (85) |  | (5) | % | 3 | % | (8) | % | 3 | % | — | %
CROP PROTECTION PRODUCT LINE |  |  |  |  |  |
| Q4 2025 vs. Q4 2024 | Percent Change Due To:
| Net Sales Change (GAAP) | Organic Change 1 (Non-GAAP) | Price & |  |  | Portfolio /
| $ | % | $ | % | Product Mix | Volume | Currency | Other
Herbicides | $ | 31 |  | 3 | % | $ | 15 |  | 1 | % | 3 | % | (2) | % | 2 | % | — | %
Insecticides | (2) |  | — | % | (12) |  | (2) | % | (5) | % | 3 | % | 2 | % | — | %
Fungicides | (48) |  | (15) | % | (55) |  | (17) | % | 2 | % | (19) | % | 2 | % | — | %
Biologicals | 22 |  | 13 | % | 14 |  | 8 | % | (9) | % | 17 | % | 5 | % | — | %
Other | (36) |  | (18) | % | (33) |  | (17) | % | (10) | % | (7) | % | (1) | % | — | %
Total | $ | (33) |  | (1) | % | $ | (71) |  | (3) | % | (1) | % | (2) | % | 2 | % | — | %

1.Organic sales is defined as price and volume and excludes currency and portfolio and other impacts, including significant items.

A-8
Corteva, Inc.
Reconciliation of Non-GAAP Measures
(Dollars in millions, except per share amounts)

PRICE - VOLUME - CURRENCY ANALYSIS
REGION |  |
| Twelve Months 2025 vs. Twelve Months 2024 | Percent Change Due To:
| Net Sales Change (GAAP) | Organic Change 1 (Non-GAAP) | Price & |  |  | Portfolio /
| $ | % | $ | % | Product Mix | Volume | Currency | Other
North America | $ | 364 |  | 4 | % | $ | 392 |  | 5 | % | 2 | % | 3 | % | (1) | % | — | %
EMEA | (14) |  | — | % | 69 |  | 2 | % | 2 | % | — | % | (2) | % | — | %
Latin America | 152 |  | 4 | % | 163 |  | 4 | % | (3) | % | 7 | % | — | % | — | %
Asia Pacific | (9) |  | (1) | % | 24 |  | 2 | % | 2 | % | — | % | (2) | % | (1) | %
Rest of World | 129 |  | 2 | % | 256 |  | 3 | % | — | % | 3 | % | (1) | % | — | %
Total | $ | 493 |  | 3 | % | $ | 648 |  | 4 | % | 1 | % | 3 | % | (1) | % | — | %
SEED |  |  |  |  |  |  |  |
| Twelve Months 2025 vs. Twelve Months 2024 | Percent Change Due To:
| Net Sales Change (GAAP) | Organic Change 1 (Non-GAAP) | Price & |  |  | Portfolio /
| $ | % | $ | % | Product Mix | Volume | Currency | Other
North America | $ | 238 |  | 4 | % | $ | 255 |  | 4 | % | 2 | % | 2 | % | — | % | — | %
EMEA | (21) |  | (1) | % | 58 |  | 4 | % | 5 | % | (1) | % | (5) | % | — | %
Latin America | 91 |  | 6 | % | 82 |  | 5 | % | 2 | % | 3 | % | 1 | % | — | %
Asia Pacific | 45 |  | 11 | % | 58 |  | 14 | % | 7 | % | 7 | % | (3) | % | — | %
Rest of World | 115 |  | 3 | % | 198 |  | 6 | % | 4 | % | 2 | % | (3) | % | — | %
Total | $ | 353 |  | 4 | % | $ | 453 |  | 5 | % | 3 | % | 2 | % | (1) | % | — | %
CROP PROTECTION |  |  |  |  |  |  |
| Twelve Months 2025 vs. Twelve Months 2024 | Percent Change Due To:
| Net Sales Change (GAAP) | Organic Change 1 (Non-GAAP) | Price & |  |  | Portfolio /
| $ | % | $ | % | Product Mix | Volume | Currency | Other
North America | $ | 126 |  | 5 | % | $ | 137 |  | 5 | % | 1 | % | 4 | % | — | % | — | %
EMEA | 7 |  | — | % | 11 |  | 1 | % | — | % | 1 | % | (1) | % | — | %
Latin America | 61 |  | 3 | % | 81 |  | 4 | % | (7) | % | 11 | % | (1) | % | — | %
Asia Pacific | (54) |  | (6) | % | (34) |  | (4) | % | — | % | (4) | % | (1) | % | (1) | %
Rest of World | 14 |  | — | % | 58 |  | 1 | % | (4) | % | 5 | % | (1) | % | — | %
Total | $ | 140 |  | 2 | % | $ | 195 |  | 3 | % | (2) | % | 5 | % | (1) | % | — | %

A-9
Corteva, Inc.
Reconciliation of Non-GAAP Measures
(Dollars in millions, except per share amounts)

SEED PRODUCT LINE |  |  |  |  |  |  |
| Twelve Months 2025 vs. Twelve Months 2024 | Percent Change Due To:
| Net Sales Change (GAAP) | Organic Change 1 (Non-GAAP) | Price & |  |  | Portfolio /
| $ | % | $ | % | Product Mix | Volume | Currency | Other
Corn | $ | 506 |  | 8 | % | $ | 577 |  | 9 | % | 3 | % | 6 | % | (1) | % | — | %
Soybeans | (49) |  | (3) | % | (48) |  | (2) | % | 2 | % | (4) | % | (1) | % | — | %
Other oilseeds | (9) |  | (1) | % | 13 |  | 2 | % | 3 | % | (1) | % | (3) | % | — | %
Other | (95) |  | (20) | % | (89) |  | (19) | % | 1 | % | (20) | % | (1) | % | — | %
Total | $ | 353 |  | 4 | % | $ | 453 |  | 5 | % | 3 | % | 2 | % | (1) | % | — | %
CROP PROTECTION PRODUCT LINE |  |  |  |  |  |
| Twelve Months 2025 vs. Twelve Months 2024 | Percent Change Due To:
| Net Sales Change (GAAP) | Organic Change 1 (Non-GAAP) | Price & |  |  | Portfolio /
| $ | % | $ | % | Product Mix | Volume | Currency | Other
Herbicides | $ | 131 |  | 4 | % | $ | 149 |  | 4 | % | — | % | 4 | % | — | % | — | %
Insecticides | (46) |  | (3) | % | (32) |  | (2) | % | (4) | % | 2 | % | (1) | % | — | %
Fungicides | 59 |  | 5 | % | 78 |  | 7 | % | — | % | 7 | % | (1) | % | (1) | %
Biologicals | 43 |  | 9 | % | 45 |  | 9 | % | (7) | % | 16 | % | — | % | — | %
Other | (47) |  | (10) | % | (45) |  | (9) | % | (6) | % | (3) | % | (1) | % | — | %
Total | $ | 140 |  | 2 | % | $ | 195 |  | 3 | % | (2) | % | 5 | % | (1) | % | — | %

1.Organic sales is defined as price and volume and excludes currency and portfolio and other impacts, including significant items.

A-10
Corteva, Inc.
Significant Items
(Dollars in millions, except per share amounts)

SIGNIFICANT ITEMS BY SEGMENT (PRE-TAX) |  |  |  |  |  |  |
| Three Months Ended December 31, |  | Twelve Months Ended December 31,
| 2025 |  | 2024 |  | 2025 |  | 2024
Seed | $ | (610) |  |  | $ | 1 |  |  | $ | (651) |  |  | $ | (49) |
Crop Protection | 5 |  |  | 12 |  |  | — |  |  | (175) |
Corporate | 3 |  |  | (31) |  |  | (7) |  |  | (91) |
Total significant items before income taxes | $ | (602) |  |  | $ | (18) |  |  | $ | (658) |  |  | $ | (315) |

SIGNIFICANT ITEMS - PRE-TAX, AFTER TAX, AND EPS IMPACTS |  |  |  |  |  |  |  |
|  | Pre-tax |  | After tax 10 |  | ($ Per Share)
|  | 2025 |  | 2024 |  | 2025 |  | 2024 |  | 2025 |  | 2024
1st Quarter |  |  |  |  |  |  |  |  |  |  |
Restructuring and asset related charges - net 1 | $ | (22) |  |  | $ | (75) |  |  | $ | (17) |  |  | $ | (56) |  |  | $ | (0.02) |  |  | $ | (0.08) |
Estimated settlement expense 2 | — |  |  | (54) |  |  | — |  |  | (41) |  |  | — |  |  | (0.06) |
Gain (loss) on sale of assets 3 | — |  |  | 4 |  |  | — |  |  | 3 |  |  | — |  |  | 0.01 |
Acquisition-related costs 4 | — |  |  | (2) |  |  | — |  |  | (1) |  |  | — |  |  | — |
AltEn facility remediation charges 5 | (37) |  |  | — |  |  | (28) |  |  | — |  |  | (0.04) |  |  | — |
Income tax items 6 | — |  |  | — |  |  | 55 |  |  | — |  |  | 0.08 |  |  | — |
1st Quarter – Total | $ | (59) |  |  | $ | (127) |  |  | $ | 10 |  |  | $ | (95) |  |  | $ | 0.02 |  |  | $ | (0.13) |
2nd Quarter |  |  |  |  |  |  |  |  |  |  |
Restructuring and asset related charges - net 1 | $ | (79) |  |  | $ | (92) |  |  | $ | (59) |  |  | $ | (69) |  |  | $ | (0.09) |  |  | $ | (0.10) |
Estimated settlement expense 2 | — |  |  | (47) |  |  | — |  |  | (36) |  |  | — |  |  | (0.05) |
Inventory write-offs 3 | — |  |  | 2 |  |  | — |  |  | 2 |  |  | — |  |  | — |
Gain (loss) on sale of assets 3 | 14 |  |  | 3 |  |  | 12 |  |  | 2 |  |  | 0.02 |  |  | — |
Acquisition-related costs 4 | — |  |  | (3) |  |  | — |  |  | (2) |  |  | — |  |  | — |
Insurance proceeds 7 | 98 |  |  | — |  |  | 74 |  |  | — |  |  | 0.11 |  |  | — |
2nd Quarter – Total | $ | 33 |  |  | $ | (137) |  |  | $ | 27 |  |  | $ | (103) |  |  | $ | 0.04 |  |  | $ | (0.15) |
3rd Quarter |  |  |  |  |  |  |  |  |  |  |
Restructuring and asset related charges - net 1 | $ | (30) |  |  | $ | (32) |  |  | $ | (23) |  |  | $ | (24) |  |  | $ | (0.03) |  |  | $ | (0.03) |
Acquisition-related costs 4 | — |  |  | (1) |  |  | — |  |  | (1) |  |  | — |  |  | — |
Income tax items 6 | — |  |  | — |  |  | — |  |  | 4 |  |  | — |  |  | — |
3rd Quarter – Total | $ | (30) |  |  | $ | (33) |  |  | $ | (23) |  |  | $ | (21) |  |  | $ | (0.03) |  |  | $ | (0.03) |
4th Quarter |  |  |  |  |  |  |  |  |  |  |
Restructuring and asset related charges - net 1 | $ | (15) |  |  | $ | (89) |  |  | $ | (11) |  |  | $ | (66) |  |  | $ | (0.02) |  |  | $ | (0.10) |
Bayer resolution 8 | (610) |  |  | — |  |  | (470) |  |  | — |  |  | (0.70) |  |  | — |
Gain (loss) on sale of assets 3 | 23 |  |  | — |  |  | 17 |  |  | — |  |  | 0.03 |  |  | — |
Insurance proceeds 7 | — |  |  | 71 |  |  | — |  |  | 54 |  |  | — |  |  | 0.08 |
Income tax items 6 | — |  |  | — |  |  | (132) |  |  | (120) |  |  | (0.19) |  |  | (0.17) |
4th Quarter – Total | $ | (602) |  |  | $ | (18) |  |  | $ | (596) |  |  | $ | (132) |  |  | $ | (0.88) |  |  | $ | (0.19) |
Annual Total 9 | $ | (658) |  |  | $ | (315) |  |  | $ | (582) |  |  | $ | (351) |  |  | $ | (0.85) |  |  | $ | (0.50) |

1.Fourth, third, second and first quarter 2025 includes restructuring and asset related benefits (charges) of ($15), ($30), $(79) and $(22), respectively. The charges primarily relate to the Crop Protection Operations Strategy Restructuring Program.
Fourth, third, second and first quarter 2024 includes restructuring and asset related benefits (charges) of $(89), $(32), $(92) and $(75), respectively. The charges primarily relate to the Crop Protection Operations Strategy Restructuring Program of $(89), $(29), $(57) and $(55) for the fourth, third, second and first quarter, respectively, and to non-cash accelerated prepaid royalty amortization expense related related to Roundup Ready 2 Yield® and Roundup Ready 2 Xtend® herbicide tolerance traits of $(35) and $(20) for the second and first quarter, respectively.
2.Second and first quarter 2024 included estimated Lorsban® related charges of $(47) and $(54), respectively.

A-11
Corteva, Inc.
Significant Items
(Dollars in millions, except per share amounts)
3.Fourth quarter 2025 includes a benefit of $23 related to the Crop Protection Operations Strategy Restructuring Program consisting of a gain on the sale of assets. Second quarter 2025 includes a benefit of $14 related to the 2022 Restructuring Actions consisting of a gain on the sale of assets.
Second and first quarter 2024 includes a benefit of $3 and $4, respectively, related to the 2022 Restructuring Actions consisting of a gain on the sale of assets. Second quarter 2024 also includes a $2 benefit associated with sales of inventory previously reserved for in association with the 2022 Restructuring Actions.
4.Second and first quarter 2024 includes acquisition-related costs relating to third-party integration costs associated with the completed acquisitions of Stoller and Symborg.
5.First quarter 2025 includes a charge relating to the increase in the remediation accrual at the AltEn facility consisting of Corteva's estimated voluntary contribution to the solid waste and wastewater remedial action plans.
6.Fourth quarter 2025 includes a tax charge of $(132) related to the establishment of a valuation allowance against the net deferred tax asset position of a legal entity in Brazil (Crop Protection business). First quarter 2025 reflects a deferred tax benefit of $55 associated with a change in a legal entity's U.S. tax characterization.
Fourth quarter 2024 includes a tax charge of $(120) related to the establishment of a valuation allowance against the net deferred tax asset position of a legal entity in Brazil (Seed business). Third quarter 2024 includes a tax benefit of $4 related to intellectual property realignment.
7.Second quarter 2025 and fourth quarter 2024 includes proceeds received related to prior significant items.
8.Fourth quarter 2025 includes a charge relating to the resolution of litigation with Bayer.
9.Earnings per share for the year may not equal the sum of quarterly earnings per share due to the changes in average share calculations.
10.Unless specifically addressed in notes above, the income tax effect on significant items was calculated based upon the enacted tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.

A-12
Corteva, Inc.
Reconciliation of Non-GAAP Measures
(Dollars in millions, except per share amounts)

Operating Earnings (Loss) Per Share (Non-GAAP) |  |  |  |  |  |  |  |
Operating earnings (loss) per share is defined as earnings (loss) per share from continuing operations – diluted, excluding the after-tax impact of significant items, the after-tax impact of separation costs, the after-tax impact of non-operating benefits (costs), the after-tax impact of amortization expense associated with intangible assets existing as of the Corteva Separation from DowDuPont, and the after-tax impact of net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting.
|  | Three Months Ended December 31,
|  | 2025 |  | 2024 |  | 2025 |  | 2024
|  | $ |  | $ |  | EPS (diluted) |  | EPS (diluted)
Income (loss) from continuing operations attributable to Corteva common stockholders (GAAP) |  | $ | (540) |  |  | $ | (52) |  |  | $ | (0.80) |  |  | $ | (0.08) |
Less: Non-operating benefits (costs), after tax 1 |  | (8) |  |  | (29) |  |  | (0.01) |  |  | (0.04) |
Less: Amortization of intangibles (existing as of Corteva Separation), after tax |  | (107) |  |  | (109) |  |  | (0.16) |  |  | (0.16) |
Less: Mark-to-market gains (losses) on certain foreign currency contracts not designated as hedges, after tax |  | 44 |  |  | (3) |  |  | 0.07 |  |  | (0.01) |
Less: Significant items benefit (charge), after tax |  | (596) |  |  | (132) |  |  | (0.88) |  |  | (0.19) |
Less: Separation costs, after tax |  | (24) |  |  | — |  |  | (0.04) |  |  | — |
Operating Earnings (Loss) (Non-GAAP) 2 |  | $ | 151 |  |  | $ | 221 |  |  | $ | 0.22 |  |  | $ | 0.32 |

|  | Twelve Months Ended December 31,
|  | 2025 |  | 2024 |  | 2025 |  | 2024
|  | $ |  | $ |  | EPS (diluted) |  | EPS (diluted)
Income (loss) from continuing operations attributable to Corteva common stockholders (GAAP) |  | $ | 1,193 |  |  | $ | 851 |  |  | $ | 1.75 |  |  | $ | 1.22 |
Less: Non-operating benefits (costs), after tax 1 |  | (36) |  |  | (127) |  |  | (0.05) |  |  | (0.18) |
Less: Amortization of intangibles (existing as of Corteva Separation), after tax |  | (434) |  |  | (459) |  |  | (0.64) |  |  | (0.67) |
Less: Mark-to-market gains (losses) on certain foreign currency contracts not designated as hedges, after tax |  | — |  |  | — |  |  | — |  |  | — |
Less: Significant items benefit (charge), after tax |  | (582) |  |  | (351) |  |  | (0.85) |  |  | (0.50) |
Less: Separation costs, after tax |  | (31) |  |  | — |  |  | (0.05) |  |  | — |
Operating Earnings (Loss) (Non-GAAP) 2 |  | $ | 2,276 |  |  | $ | 1,788 |  |  | $ | 3.34 |  |  | $ | 2.57 |

1.Non-operating benefits (costs) consists of non-operating pension and other post-employment benefit (OPEB) credits (costs), tax indemnification adjustments and environmental remediation and legal costs associated with legacy businesses and sites. Tax indemnification adjustments relate to changes in indemnification balances, as a result of the application of the terms of the Tax Matters Agreement, between Corteva and Dow and/or DuPont that are recorded by the company as pre-tax income or expense.
2.Refer to page A-13 for the Non-GAAP reconciliation of operating EBITDA to operating earnings (loss) per share.

A-13
Corteva, Inc.
Operating EBITDA to Operating Earnings (Loss) Per Share
(Dollars in millions, except per share amounts)

Operating EBITDA to Operating Earnings (Loss) Per Share
|  | Three Months Ended December 31, |  | Twelve Months Ended December 31,
|  | 2025 |  | 2024 |  | 2025 |  | 2024
Operating EBITDA (Non-GAAP) 1 |  | $ | 446 |  |  | $ | 525 |  |  | $ | 3,848 |  |  | $ | 3,376 |
Depreciation |  | (147) |  |  | (138) |  |  | (559) |  |  | (542) |
Amortization of intangibles (post Corteva Separation) |  | (20) |  |  | (20) |  |  | (78) |  |  | (82) |
Interest income |  | 44 |  |  | 39 |  |  | 136 |  |  | 132 |
Interest expense |  | (46) |  |  | (60) |  |  | (180) |  |  | (233) |
(Provision for) benefit from income taxes on continuing operations before significant items, separation costs, non-operating benefits (costs), amortization of intangibles (existing as of Corteva Separation), mark-to-market gains (losses) on certain foreign currency contracts not designated as hedges, and exchange gains (losses) (Non-GAAP) 1 |  | (61) |  |  | (80) |  |  | (702) |  |  | (604) |
Base income tax rate from continuing operations (Non-GAAP) 1 |  | 22.0 | % |  | 23.1 | % |  | 22.2 | % |  | 22.8 | %
Exchange gains (losses), after tax 2 |  | (62) |  |  | (43) |  |  | (178) |  |  | (247) |
Net (income) loss attributable to noncontrolling interests |  | (3) |  |  | (2) |  |  | (11) |  |  | (12) |
Operating Earnings (Loss) (Non-GAAP) 1 |  | $ | 151 |  |  | $ | 221 |  |  | $ | 2,276 |  |  | $ | 1,788 |
Diluted shares (in millions) |  | 674.7 |  |  | 687.3 |  |  | 681.4 |  |  | 696.0 |
Operating Earnings (Loss) Per Share (Non-GAAP) 1 |  | $ | 0.22 |  |  | $ | 0.32 |  |  | $ | 3.34 |  |  | $ | 2.57 |

1. Refer to pages A-5 through A-9, and A-12 and A-14 for Non-GAAP reconciliations.
2. Refer to page A-15 for pre-tax and after tax impacts of exchange gains (losses).

A-14
Corteva, Inc.
Reconciliation of Non-GAAP Measures
(Dollars in millions)

Reconciliation of Base Income Tax Rate to Effective Income Tax Rate
Base income tax rate is defined as the effective income tax rate less the effect of exchange gains (losses), significant items, separation costs, amortization of intangibles (existing as of Corteva Separation), mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges, and non-operating (benefits) costs.
| Three Months Ended December 31, |  | Twelve Months Ended December 31,
| 2025 |  | 2024 |  | 2025 |  | 2024
Income (loss) from continuing operations before income taxes (GAAP) | $ | (530) |  |  | $ | 88 |  |  | $ | 1,688 |  |  | $ | 1,275 |
Add: Significant items (benefit) charge 1 | 602 |  |  | 18 |  |  | 658 |  |  | 315 |
Separation costs | 28 |  |  | — |  |  | 35 |  |  | — |
Non-operating (benefits) costs | 12 |  |  | 42 |  |  | 39 |  |  | 174 |
Amortization of intangibles (existing as of Corteva Separation) | 139 |  |  | 144 |  |  | 566 |  |  | 603 |
Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges | (58) |  |  | 4 |  |  | — |  |  | — |
Less: Exchange gains (losses) 2 | (84) |  |  | (50) |  |  | (181) |  |  | (284) |
Income (loss) from continuing operations before income taxes, significant items, separation costs, non-operating (benefits) costs, amortization of intangibles (existing as of Corteva Separation), mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges, and exchange gains (losses) (Non-GAAP) | $ | 277 |  |  | $ | 346 |  |  | $ | 3,167 |  |  | $ | 2,651 |
Provision for (benefit from) income taxes on continuing operations (GAAP) | $ | 7 |  |  | $ | 138 |  |  | $ | 484 |  |  | $ | 412 |
Add: Tax (expenses) benefits on significant items (benefit) charge 1 | 6 |  |  | (114) |  |  | 76 |  |  | (36) |
Tax benefits on separation costs | 4 |  |  | — |  |  | 4 |  |  | — |
Tax benefits on non-operating (benefits) costs | 4 |  |  | 13 |  |  | 3 |  |  | 47 |
Tax benefits on amortization of intangibles (existing as of Corteva Separation) | 32 |  |  | 35 |  |  | 132 |  |  | 144 |
Tax (expenses) benefits on mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges | (14) |  |  | 1 |  |  | — |  |  | — |
Tax benefits on exchange gains (losses) 2 | 22 |  |  | 7 |  |  | 3 |  |  | 37 |
Provision for (benefit from) income taxes on continuing operations before significant items, separation costs, non-operating (benefits) costs, amortization of intangibles (existing as of Corteva Separation), mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges, and exchange gains (losses) (Non-GAAP) | $ | 61 |  |  | $ | 80 |  |  | $ | 702 |  |  | $ | 604 |
Effective income tax rate (GAAP) | (1.3) | % |  | 156.8 | % |  | 28.7 | % |  | 32.3 | %
Significant items, separation costs, non-operating (benefits) costs, amortization of intangibles (existing as of Corteva Separation), and mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges effect | 21.5 | % |  | (132.1) | % |  | (5.3) | % |  | (8.3) | %
Tax rate from continuing operations before significant items, separation costs, non-operating (benefits) costs, amortization of intangibles (existing as of Corteva Separation), and mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges | 20.2 | % |  | 24.7 | % |  | 23.4 | % |  | 24.0 | %
Exchange gains (losses), net effect 2 | 1.8 | % |  | (1.6) | % |  | (1.2) | % |  | (1.2) | %
Base income tax rate from continuing operations (Non-GAAP) | 22.0 | % |  | 23.1 | % |  | 22.2 | % |  | 22.8 | %
1. See page A-10 for further detail on the significant items table.
2. See page A-15 for further details of exchange gains (losses).

A-15
Corteva, Inc.
(Dollars in millions, except per share amounts)

Exchange Gains/Losses |  |  |  |  |  |  |  |
The Company routinely uses foreign currency exchange contracts to offset its net exposures, by currency, related to the foreign currency-denominated monetary assets and liabilities. The objective of this program is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes on net monetary asset positions. The hedging program gains (losses) are largely taxable (tax deductible) in the United States (U.S.), whereas the offsetting exchange gains (losses) on the remeasurement of the net monetary asset positions are often not taxable (tax deductible) in their local jurisdictions. The net pre-tax exchange gains (losses) are recorded in other income (expense) - net and the related tax impact is recorded in provision for (benefit from) income taxes on continuing operations in the Consolidated Statements of Operations.
|  | Three Months Ended December 31, |  | Twelve Months Ended December 31,
|  | 2025 |  | 2024 |  | 2025 |  | 2024
Subsidiary Monetary Position Gain (Loss) |  |  |  |  |  |  |  |
Pre-tax exchange gains (losses) |  | $ | (81) |  |  | $ | 47 |  |  | $ | (254) |  |  | $ | (152) |
Local tax (expenses) benefits |  | 21 |  |  | (12) |  |  | 11 |  |  | 11 |
Net after tax impact from subsidiary exchange gains (losses) |  | $ | (60) |  |  | $ | 35 |  |  | $ | (243) |  |  | $ | (141) |
Hedging Program Gain (Loss) |  |  |  |  |  |  |  |
Pre-tax exchange gains (losses) |  | $ | (3) |  |  | $ | (97) |  |  | $ | 73 |  |  | $ | (132) |
Tax (expenses) benefits |  | 1 |  |  | 19 |  |  | (8) |  |  | 26 |
Net after tax impact from hedging program exchange gains (losses) |  | $ | (2) |  |  | $ | (78) |  |  | $ | 65 |  |  | $ | (106) |
Total Exchange Gain (Loss) |  |  |  |  |  |  |  |
Pre-tax exchange gains (losses) |  | $ | (84) |  |  | $ | (50) |  |  | $ | (181) |  |  | $ | (284) |
Tax (expenses) benefits |  | 22 |  |  | 7 |  |  | 3 |  |  | 37 |
Net after tax exchange gains (losses) |  | $ | (62) |  |  | $ | (43) |  |  | $ | (178) |  |  | $ | (247) |
Noncontrolling interest adjustment |  | — |  |  | — |  |  | — |  |  | 1 |
Net after tax exchange gain (loss) attributable to Corteva |  | $ | (62) |  |  | $ | (43) |  |  | $ | (178) |  |  | $ | (246) |
As shown above, the "Total Exchange Gain (Loss)" is the sum of the "Subsidiary Monetary Position Gain (Loss)" and the "Hedging Program (Loss) Gain."

A-16
Corteva, Inc.
Reconciliation of Non-GAAP Measures
(Dollars in millions)

Free Cash Flow (Non-GAAP) |  |  |  |
Free Cash Flow is defined as cash provided by (used for) operating activities – continuing operations, less capital expenditures.
|  |  | Twelve Months Ended December 31,
|  |  | 2025 |  | 2024
Cash provided by (used for) operating activities - continuing operations (GAAP) | $ | 3,457 |  |  | $ | 2,296 |
Less: Capital expenditures | (591) |  |  | (597) |
Free Cash Flow (Non-GAAP) | $ | 2,866 |  |  | $ | 1,699 |